205 related articles for article (PubMed ID: 37415556)
1. Nanoparticles Mediated the Diagnosis and Therapy of Glioblastoma: Bypass or Cross the Blood-Brain Barrier.
Song X; Qian H; Yu Y
Small; 2023 Nov; 19(45):e2302613. PubMed ID: 37415556
[TBL] [Abstract][Full Text] [Related]
2. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
[TBL] [Abstract][Full Text] [Related]
3. Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications.
Lakshmi BA; Kim YJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163563
[TBL] [Abstract][Full Text] [Related]
4. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
Gutkin A; Cohen ZR; Peer D
Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
[TBL] [Abstract][Full Text] [Related]
5. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.
Ganipineni LP; Danhier F; Préat V
J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958
[TBL] [Abstract][Full Text] [Related]
6.
Gallego L; Ceña V
Expert Opin Drug Deliv; 2020 Nov; 17(11):1541-1554. PubMed ID: 32791861
[TBL] [Abstract][Full Text] [Related]
7. Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment
Yang J; Shi Z; Liu R; Wu Y; Zhang X
Theranostics; 2020; 10(7):3223-3239. PubMed ID: 32194864
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine for glioblastoma: Progress and future prospects.
Khan I; Baig MH; Mahfooz S; Imran MA; Khan MI; Dong JJ; Cho JY; Hatiboglu MA
Semin Cancer Biol; 2022 Nov; 86(Pt 2):172-186. PubMed ID: 35760272
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.
Aparicio-Blanco J; Sanz-Arriazu L; Lorenzoni R; Blanco-Prieto MJ
Int J Pharm; 2020 May; 581():119283. PubMed ID: 32240807
[TBL] [Abstract][Full Text] [Related]
10. Overcoming delivery barriers in immunotherapy for glioblastoma.
Rui Y; Green JJ
Drug Deliv Transl Res; 2021 Dec; 11(6):2302-2316. PubMed ID: 34053034
[TBL] [Abstract][Full Text] [Related]
11. Drug delivery approaches for the treatment of glioblastoma multiforme.
Fakhoury M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
[TBL] [Abstract][Full Text] [Related]
13. Immunoengineering in glioblastoma imaging and therapy.
Zanganeh S; Georgala P; Corbo C; Arabi L; Ho JQ; Javdani N; Sepand MR; Cruickshank K; Campesato LF; Weng CH; Hemayat S; Andreou C; Alvim R; Hutter G; Rafat M; Mahmoudi M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1575. PubMed ID: 31407522
[TBL] [Abstract][Full Text] [Related]
14. Multi-ligand functionalized blood-to-tumor sequential targeting strategies in the field of glioblastoma nanomedicine.
Martins C; Sarmento B
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1893. PubMed ID: 37186374
[TBL] [Abstract][Full Text] [Related]
15. New Perspectives in Glioblastoma: Nanoparticles-based Approaches.
Luciano R; Battafarano G; Saracino R; Rossi M; Perrotta A; Manco M; Muraca M; Del Fattore A
Curr Cancer Drug Targets; 2017; 17(3):203-220. PubMed ID: 27528362
[TBL] [Abstract][Full Text] [Related]
16. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
17. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment.
Pinel S; Thomas N; Boura C; Barberi-Heyob M
Adv Drug Deliv Rev; 2019 Jan; 138():344-357. PubMed ID: 30414495
[TBL] [Abstract][Full Text] [Related]
18. An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy.
Taiarol L; Formicola B; Magro RD; Sesana S; Re F
Nanomedicine (Lond); 2020 Aug; 15(19):1861-1871. PubMed ID: 32731839
[TBL] [Abstract][Full Text] [Related]
19. Novel delivery strategies for glioblastoma.
Zhou J; Atsina KB; Himes BT; Strohbehn GW; Saltzman WM
Cancer J; 2012; 18(1):89-99. PubMed ID: 22290262
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies.
Liu D; Dai X; Ye L; Wang H; Qian H; Cheng H; Wang X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1838. PubMed ID: 35959642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
